Literature DB >> 8370596

Use of O-glycosylation-defective human lymphoid cell lines and flow cytometry to delineate the specificity of Moluccella laevis lectin and monoclonal antibody 5F4 for the Tn antigen (GalNAc alpha 1-O-Ser/Thr).

M Thurnher1, H Clausen, N Sharon, E G Berger.   

Abstract

The Tn antigen (GalNAc alpha 1-O-Ser/Thr) is a disease-related O-linked (mucin-type) carbohydrate neoantigen which is expressed in idiopathic Tn syndrome, AIDS, T-cell lymphoma and in many carcinomas. In the present study, we took advantage of a Tn antigen expressing T-lymphocyte clone derived from a patient with the idiopathic form of the Tn syndrome and the Tn+ Jurkat cell line to characterize new reagents that should identify Tn antigens (monoclonal antibody 5F4 and a lectin newly isolated from Moluccella laevis seeds). Flow cytometry revealed that both reagents strongly bound to Tn antigen expressing T lymphocytes but not to normal donor T cells, which are Tn negative. In contrast to mAb 5F4, Moluccella laevis lectin weakly bound to normal donor cells after sialidase pretreatment, indicating its broader specificity. N-Acetyl-D-galactosamine at a concentration of 100 mM significantly reduced antibody binding and abolished lectin binding, completely demonstrating the sugar specificity of both reagents. These reagents should be useful tools in glycobiology and for clinical purposes.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8370596     DOI: 10.1016/0165-2478(93)90095-j

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  10 in total

1.  A unique molecular chaperone Cosmc required for activity of the mammalian core 1 beta 3-galactosyltransferase.

Authors:  Tongzhong Ju; Richard D Cummings
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-03       Impact factor: 11.205

2.  Characterization of an immunodominant cancer-specific O-glycopeptide epitope in murine podoplanin (OTS8).

Authors:  Catharina Steentoft; Katrine T Schjoldager; Emiliano Cló; Ulla Mandel; Steven B Levery; Johannes W Pedersen; Knud Jensen; Ola Blixt; Henrik Clausen
Journal:  Glycoconj J       Date:  2010-08-19       Impact factor: 2.916

3.  Identification of Tn antigen O-GalNAc-expressing glycoproteins in human carcinomas using novel anti-Tn recombinant antibodies.

Authors:  Yasuyuki Matsumoto; Matthew R Kudelka; Melinda S Hanes; Sylvain Lehoux; Sucharita Dutta; Mark B Jones; Kathryn A Stackhouse; Gabrielle E Cervoni; Jamie Heimburg-Molinaro; David F Smith; Tongzhong Ju; Elliot L Chaikof; Richard D Cummings
Journal:  Glycobiology       Date:  2020-04-20       Impact factor: 4.313

4.  Targeting a Tumor-Specific Epitope on Podocalyxin Increases Survival in Human Tumor Preclinical Models.

Authors:  Diana Canals Hernaez; Michael R Hughes; Yicong Li; Ilaria Mainero Rocca; Pamela Dean; Julyanne Brassard; Erin M Bell; Ismael Samudio; Anne-Marie Mes-Masson; Yoshiki Narimatsu; Henrik Clausen; Ola Blixt; Calvin D Roskelley; Kelly M McNagny
Journal:  Front Oncol       Date:  2022-05-04       Impact factor: 5.738

5.  A luminal glycoprotein drives dose-dependent diameter expansion of the Drosophila melanogaster hindgut tube.

Authors:  Zulfeqhar A Syed; Anne-Laure Bougé; Sunitha Byri; Tina M Chavoshi; Erika Tång; Hervé Bouhin; Iris F van Dijk-Härd; Anne Uv
Journal:  PLoS Genet       Date:  2012-08-02       Impact factor: 5.917

6.  Mapping of truncated O-glycans in cancers of epithelial and non-epithelial origin.

Authors:  Troels Boldt Rømer; Mikkel Koed Møller Aasted; Sally Dabelsteen; Aaron Groen; Julia Schnabel; Edwin Tan; Johannes Wirenfeldt Pedersen; Amalie Dahl Haue; Hans Heugh Wandall
Journal:  Br J Cancer       Date:  2021-09-15       Impact factor: 9.075

Review 7.  Plant Lectins Targeting O-Glycans at the Cell Surface as Tools for Cancer Diagnosis, Prognosis and Therapy.

Authors:  Guillaume Poiroux; Annick Barre; Els J M van Damme; Hervé Benoist; Pierre Rougé
Journal:  Int J Mol Sci       Date:  2017-06-09       Impact factor: 5.923

Review 8.  Targeting Tumor Glycans for Cancer Therapy: Successes, Limitations, and Perspectives.

Authors:  Nora Berois; Alvaro Pittini; Eduardo Osinaga
Journal:  Cancers (Basel)       Date:  2022-01-27       Impact factor: 6.639

9.  Polymeric nanoparticles targeting Sialyl-Tn in gastric cancer: A live tracking under flow conditions.

Authors:  Francisca Diniz; Maria Azevedo; Flávia Sousa; Hugo Osório; Diana Campos; Paula Sampaio; Joana Gomes; Bruno Sarmento; Celso A Reis
Journal:  Mater Today Bio       Date:  2022-09-03

10.  Glycan elongation beyond the mucin associated Tn antigen protects tumor cells from immune-mediated killing.

Authors:  Caroline B Madsen; Kirstine Lavrsen; Catharina Steentoft; Malene B Vester-Christensen; Henrik Clausen; Hans H Wandall; Anders Elm Pedersen
Journal:  PLoS One       Date:  2013-09-06       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.